Study: Merck hep C combo effective in kidney disease patients

Study: Merck hep C combo effective in kidney disease patients Earlier this year, the FDA granted Merck breakthrough status for its combined grazoprevir/elbasvir combination medication for treatment of hepattis C (HCV). Merck is also targeting patients with severe kidney impairment … Continue reading

Hepatitis C immunity study launched by Dal researcher in PEI correctional centre

Hepatitis C immunity study launched by Dal researcher in PEI correctional centre “We have newly approved oral medications for hepatitis C with proven cure rates of 90 to 97 per cent and minimal side effects,” explains Dr. Barrett. “The challenge … Continue reading

Drug Regimen Cures Hepatitis C in Most Liver Transplant Patients in Study

Drug Regimen Cures Hepatitis C in Most Liver Transplant Patients in Study … Kwo said liver transplantation in the United States is mainly the result of cirrhosis — liver scarring — caused by hepatitis C. Liver transplant patients with the … Continue reading

Bristol-Myers Hepatitis C Therapy With Sovaldi Meets Study Goals

Bristol-Myers Hepatitis C Therapy With Sovaldi Meets Study Goals Bristol has been focusing on the hepatitis C treatment—called daclatasvir—in combination with Sovaldi following the U.S. Food and Drug Administration's rejection of its new drug application in November for daclatasvir in … Continue reading